These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16486034)

  • 41. [Pathophysiological mechanisms of dengue fever: critical review of current concepts].
    Deparis X; Maréchal V; Matheus S
    Med Trop (Mars); 2009 Aug; 69(4):351-7. PubMed ID: 19725385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests.
    Okuno Y; Fukunaga T; Srisupaluck S; Kasemsarn P; Dharakul C; Sangkawibha N
    Biken J; 1980 Sep; 23(3):113-21. PubMed ID: 7458894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporary Cross-Immunity as a Plausible Driver of Asynchronous Cycles of Dengue Serotypes.
    Fung T; Clapham HE; Chisholm RA
    Bull Math Biol; 2023 Nov; 85(12):124. PubMed ID: 37962713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    Halstead SB; Venkateshan CN; Gentry MK; Larsen LK
    J Immunol; 1984 Mar; 132(3):1529-32. PubMed ID: 6607288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
    Yamanaka A; Suzuki R; Konishi E
    Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent progress in dengue vaccine research and development.
    Miller N
    Curr Opin Mol Ther; 2010 Feb; 12(1):31-8. PubMed ID: 20140814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges for the formulation of a universal vaccine against dengue.
    Chokephaibulkit K; Perng GC
    Exp Biol Med (Maywood); 2013 May; 238(5):566-78. PubMed ID: 23856907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A mathematical model to evaluate the role of memory B and T cells in heterologous secondary dengue infection.
    Rubio FA; Yang HM
    J Theor Biol; 2022 Feb; 534():110961. PubMed ID: 34774663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A mathematical model to describe antibody-dependent enhancement and assess the effect of limiting cloning for plasma cells in heterologous secondary dengue infection.
    Alves Rubio F; Mo Yang H
    Math Med Biol; 2022 Jun; 39(2):169-196. PubMed ID: 35380162
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe dengue progression beyond enhancement.
    Odio CD; Aogo RA; Lowman KE; Katzelnick LC
    Nat Immunol; 2023 Dec; 24(12):1967-1969. PubMed ID: 38012410
    [No Abstract]   [Full Text] [Related]  

  • 52. Cross immunity protection and antibody-dependent enhancement in a distributed delay dynamic model.
    Steindorf V; Oliva S; Wu J
    Math Biosci Eng; 2022 Jan; 19(3):2950-2984. PubMed ID: 35240815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Step in the Right Direction.
    Halstead SB
    J Infect Dis; 2020 Aug; 222(5):712-714. PubMed ID: 32391556
    [No Abstract]   [Full Text] [Related]  

  • 54. Multiple stable recurrent outbreaks and predictability in seasonally forced nonlinear epidemic models.
    Schwartz IB
    J Math Biol; 1985; 21(3):347-61. PubMed ID: 4031698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shifting patterns of dengue three years after Zika virus emergence in Brazil.
    Pinotti F; Giovanetti M; de Lima MM; de Cerqueira EM; Alcantara LCJ; Gupta S; Recker M; Lourenço J
    Nat Commun; 2024 Jan; 15(1):632. PubMed ID: 38245500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Linking mosquito surveillance to dengue fever through Bayesian mechanistic modeling.
    Leach CB; Hoeting JA; Pepin KM; Eiras AE; Hooten MB; Webb CT
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008868. PubMed ID: 33226987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Challenges in dengue research: A computational perspective.
    Lourenço J; Tennant W; Faria NR; Walker A; Gupta S; Recker M
    Evol Appl; 2018 Apr; 11(4):516-533. PubMed ID: 29636803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.
    Aguiar M; Stollenwerk N; Halstead SB
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005179. PubMed ID: 28002420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines.
    Shim E
    Am J Trop Med Hyg; 2016 Nov; 95(5):1137-1147. PubMed ID: 27601519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Serotype Interactions and Seasonality in Dengue Model Selection and Control: Insights from a Pattern Matching Approach.
    Ten Bosch QA; Singh BK; Hassan MR; Chadee DD; Michael E
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004680. PubMed ID: 27159023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.